Your browser doesn't support javascript.
loading
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
Fraticelli, Laurie; Freyssenge, Julie; Promé-Combel, Emilie; Agnellet, Eléonore; Dargaud, Yesim; Chamouard, Valérie.
Affiliation
  • Fraticelli L; Laboratory P2S (Health Systemic Process), UR 4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Freyssenge J; Research on Healthcare Performance RESHAPE, INSERM U1290, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Promé-Combel E; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Agnellet E; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Dargaud Y; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Chamouard V; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
JMIR Res Protoc ; 12: e43091, 2023 Mar 08.
Article in En | MEDLINE | ID: mdl-36884286
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Language: En Journal: JMIR Res Protoc Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Language: En Journal: JMIR Res Protoc Year: 2023 Type: Article Affiliation country: France